研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

炎症体蛋白在肿瘤发展过程中支撑 DNA 损伤复合物。

Inflammasome protein scaffolds the DNA damage complex during tumor development.

发表日期:2024 Oct 14
作者: Cheng Shen, Abhimanu Pandey, Daniel Enosi Tuipulotu, Anukriti Mathur, Lixinyu Liu, Haoyu Yang, Nilanthi K Adikari, Chinh Ngo, Weidong Jing, Shouya Feng, Yuwei Hao, Anyang Zhao, Max Kirkby, Melan Kurera, Jing Zhang, Shweta Venkataraman, Cheng Liu, Renhua Song, Justin J-L Wong, Ulrike Schumann, Riccardo Natoli, Jiayu Wen, Liman Zhang, Nadeem O Kaakoush, Si Ming Man
来源: NATURE IMMUNOLOGY

摘要:

炎性体传感器激活细胞信号传导机制以驱动炎症和细胞死亡过程。炎症小体还独立于典型功能控制某些疾病的发展。在这里,我们发现炎性体蛋白 NLR 家族 CARD 结构域蛋白 4 (NLRC4) 可以减弱 Apcmin/ 小鼠模型中肿瘤的发展。这种反应独立于 NLRP3、NLRP6、NLR 家族凋亡抑制蛋白(黑色素瘤 2 中不存在)、含有 caspase 募集结构域的凋亡相关斑点样蛋白、caspase-1 和 caspase-11 的炎症小体信号传导。 NLRC4 与 DNA 损伤感知共济失调毛细血管扩张症和 Rad3 相关 (ATR)-ATR 相互作用蛋白 (ATRIP)-尤文肿瘤相关抗原 1 (ETAA1) 复合物相互作用,促进检查点接头蛋白 claspin 的募集,从而许可激酶检查点激酶 1 (CHK1) 的激活。基因毒性诱导的 NLRC4-ATR-ATRIP-ETAA1 复合物激活驱动了肿瘤抑制性 DNA 损伤反应和 CHK1 激活,并进一步减弱了 DNA 损伤的积累。这些发现证明了炎性体蛋白在促进 DNA 损伤反应和介导癌症保护方面的非炎症功能。© 2024。作者获得 Springer Nature America, Inc. 的独家许可。
Inflammasome sensors activate cellular signaling machineries to drive inflammation and cell death processes. Inflammasomes also control the development of certain diseases independently of canonical functions. Here, we show that the inflammasome protein NLR family CARD domain-containing protein 4 (NLRC4) attenuated the development of tumors in the Apcmin/+ mouse model. This response was independent of inflammasome signaling by NLRP3, NLRP6, NLR family apoptosis inhibitory proteins, absent in melanoma 2, apoptosis-associated speck-like protein containing a caspase recruitment domain, caspase-1 and caspase-11. NLRC4 interacted with the DNA-damage-sensing ataxia telangiectasia and Rad3-related (ATR)-ATR-interacting protein (ATRIP)-Ewing tumor-associated antigen 1 (ETAA1) complex to promote the recruitment of the checkpoint adapter protein claspin, licensing the activation of the kinase checkpoint kinase-1 (CHK1). Genotoxicity-induced activation of the NLRC4-ATR-ATRIP-ETAA1 complex drove the tumor-suppressing DNA damage response and CHK1 activation, and further attenuated the accumulation of DNA damage. These findings demonstrate a noninflammatory function of an inflammasome protein in promoting the DNA damage response and mediating protection against cancer.© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.